Ruyi Chen

Ruyi Chen

Auto-generated profile, based on publicly available information

Ruyi Chen

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2023 in Briefings in Bioinformatics
Verified
Journal Article
Open access
PDF file
RCRuyi Chen
Ruyi Chen
FLFuyi Li
Fuyi Li
XGXudong Guo
Xudong Guo
YBYue Bi
Yue Bi
CLChen Li
Chen Li
Jiangning SongJiangning Song
Jiangning Song
A-to-I editing is the most prevalent RNA editing event, which refers to the change of adenosine (A) bases to inosine (I) bases in double-stranded RNAs. Several studies have revealed that A-to-I editing can regulate cellular processes and is associated with various human diseases. Therefore, accurate identification of A-to-I editing sites is crucial for understanding RNA-level (i.e. transcriptional) modifications and their potential roles in molecular functions. To date, various computational approaches for A-to-I editing site identification have been developed; however, their performance is still unsatisfactory and needs further improvement. In this study, we developed a novel stacked-ensemble learning model, ATTIC (A-To-I ediTing predICtor), to accurately identify A-to-I editing sites across three species, including Homo sapiens, Mus musculus and Drosophila melanogaster. We first comprehensively evaluated 37 RNA sequence-derived features combined with 14 popular machine learning algorithms. Then, we selected the optimal base models to build a series of stacked ensemble models. The final ATTIC framework was developed based on the optimal models improved by the feature selection strategy for specific species. Extensive cross-validation and independent tests illustrate that ATTIC outperforms state-of-the-art tools for predicting A-to-I editing sites. We also developed a web server for ATTIC, which is publicly available at http://web.unimelb-bioinfortools.cloud.edu.au/ATTIC/. We anticipate that ATTIC can be utilized as a useful tool to accelerate the identification of A-to-I RNA editing events and help characterize their roles in post-transcriptional regulation.

1 December 2023 in Medcomm
Verified
Journal Article
Open access
YWYan Wang
Yan Wang
SJShengjie Jin
Shengjie Jin
QZQiqi Zhuang
Qiqi Zhuang
NLNa Liu
Na Liu
RCRuyi Chen
Ruyi Chen
JSJie Sun
Jie Sun
Chimeric antigen receptor (CAR) T cells have been successfully used in adoptive cell therapy for malignancies. However, some obstacles, including side effects such as graft‐versus‐host disease and cytokine release syndrome, therapy resistance, limited sources, as well as high cost, limited the application of CAR T cells. Recently, CAR natural killer (NK) cells have been pursued as the effector cells for adoptive immunotherapy for their attractive merits of strong intrinsic antitumor activity and relatively mild side effects. Additionally, CAR NK cells can be available from various sources and do not require strict human leukocyte antigen matching, which suggests them as promising “off‐the‐shelf” products for clinical application. Although the use of CAR NK cells is restrained by the limited proliferation and impaired efficiency within the immunosuppressive tumor microenvironment, further investigation in optimizing CAR structure and combination therapies will overcome these challenges. This review will summarize the advancement of CAR NK cells, CAR NK cell manufacture, the clinical outcomes of CAR NK therapy, the challenges in the field, and prospective solutions. Besides, we will discuss the emerging application of other immune cells for CAR engineering. Collectively, this comprehensive review will provide a valuable and informative summary of current progress and evaluate challenges and future opportunities of CAR NK cells in tumor treatment.

21 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRuyi Chen
Ruyi Chen
GFGabriel Foley
Gabriel Foley
MBMikael Bodén
Mikael Bodén
Summary: Classical phylogenetics assumes site independence, potentially overlooking epistasis. Protein language models capture dependencies in conserved structural and functional domains across the protein universe. Here, we ask whether MSA Transformer, which takes a multiple sequence alignment (MSA) as input, captures evolutionary distance and to what extent its representations reflect epistasis in protein sequence evolution, neither of which are explicitly available during training. Systematic shuffling of natural and simulated MSAs demonstrates the model exploits column-wise conservation to distinguish phylogenetic relationships. Using internal embeddings, we reconstruct trees that are markedly consistent with trees generated by maximum likelihood inference. Applying this approach to both the RNA-dependent RNA polymerase of RNA viruses and the nucleo-cytoplasmic large DNA virus domain, we recover both established and novel evolutionary relationships. We conclude that MSA Transformer complements, rather than replaces, classical inference for more accurate histories of protein families.

14 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
RCRuyi Chen
Ruyi Chen
NPNathan Palpant
Nathan Palpant
GFGabriel Foley
Gabriel Foley
MBMikael Bodén
Mikael Bodén
Predicting the functional impact of genetic variants remains a fundamental challenge in genomics. Existing models focus on protein-intrinsic defects yet overlook regulatory constraints embedded within coding sequences. Here, we couple a codon language model (CaLM) with a protein language model (ESM-2) to dissect the drivers of variant pathogenicity. On ClinVar data, both modalities contribute near-equally to distinguishing pathogenic from benign variants. Evaluation across Deep Mutational Scanning and CRISPR-Based Genome Editing platforms in ClinMAVE reveals that loss-of-function variants are governed primarily by residue-level features, whereas gain-of-function variants show a greater relative contribution from codon-level constraints, albeit in a gene-specific manner. A controlled comparison of identical variants in BRCA1 and TP53 further suggests that codon-level signals are elevated in the endogenous genomic context. Together, these findings indicate that pathogenicity reflects both the “product” and the “process,” and that the experimental platform may influence which dimension is observable.